What is Terason?
Terason is a prominent manufacturer specializing in portable ultrasound machines, designed to improve diagnostic capabilities and workflow efficiency across various medical disciplines. Their product portfolio includes sophisticated models like the uSmart 3300 NexGen and uSmart 3200T, which incorporate advanced features such as Dynamic Depth Resolution and Enhanced Needle Visualization. The company caters to a broad spectrum of healthcare providers, including those in emergency medicine, cardiology, and musculoskeletal care, offering comprehensive educational programs and technical support to maximize the utility of their ultrasound systems.
How much funding has Terason raised?
Terason has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Terason
PPP
Public-Private Partnership
What's next for Terason?
With the infusion of $350K as a major strategic investment and a total capital base of $350K, Terason is well-positioned for its next phase of growth. This late-stage funding context suggests a focus on market expansion, potential product line enhancements, or strategic partnerships to solidify its competitive edge in the portable ultrasound market. The company's commitment to innovation in medical imaging technology, coupled with its established client base, indicates a trajectory aimed at further capturing market share and advancing patient care through accessible and advanced diagnostic tools.
See full Terason company page
